Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease

Authors:

Abstract
No abstract available
Funding Information
  • Pfizer
  • Nippon Kayaku
  • Novartis
  • AbbVie Canada
  • Roche
  • Seres Therapeutics (4SC)
  • Yale University
  • Diagnostic Services Manitoba
  • Eli Lilly and Company
  • Takeda Canada
  • Schering-Plough
  • Boehringer Ingelheim
  • Janssen Pharmaceutica
  • Abbott Laboratories
  • Shire
  • Gilead Sciences
  • MedImmune
  • Teva Pharmaceutical Industries
  • Ferring Pharmaceuticals

This publication has 28 references indexed in Scilit: